ClinicalTrials.govpublic full text
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
lupus erythematosus, cutaneous, lupus erythematosus, systemic, cutaneous lupus erythematosus, systemic lupus erythematosus, lupus erythematosus, human anti-il 6 monoclonal antibody, sirukumab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915319
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.